524
Participants
Start Date
August 9, 2018
Primary Completion Date
May 21, 2021
Study Completion Date
July 30, 2026
Trastuzumab deruxtecan (T-DXd)
T-DXd is sterile lyophilized powder reconstituted into a sterile aqueous solution (100 mg/5 mL) to be administered intravenously.
Ado-trastuzumab emtansine (T-DM1)
The treatment will be in accordance with the approved label.
National Taiwan University Hospital, Taipei
Koo Foundation, Sun Yat-Sen Cancer Center, Taipei
National Cheng Kung University Hospital, Tainan City
Institut Jules-Bordet, Brussels
Universitair Ziekenhuis Brussel, Brussels
The Tweed Hospital, Tweed Heads
Universitair Ziekenhuis Antwerpen, Edegem
Peter MacCallum Cancer, Melbourne
Universitaire Ziekenhuizen Leuven, Leuven
Box Hill Hospital, Box Hill
Peninsula and South Eastern Haematology & Oncology Group, Frankston
Princess Alexandra Hospital, Woolloongabba
CHU UCL Namur site de Sainte Elisabeth, Namur
Hospital Infanta Cristina, Badajoz
St John of God Subiaco Hospital, Subiaco
IOB-Institute of Oncology, Barcelona
AZ Sint-Lucas - Campus Sint-Lucas, Ghent
Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino
Taipei Veterans General Hospital, Taipei
North Shore Hematology Oncology Associates, PC, East Setauket
Seoul National University Bundang Hospital, Seongnam-si
Hôpital Nord - CHU Marseille, Marseille
Centre François Baclesse, Caen
University of Rochester, Rochester
Complejo Hospitalario Universitario A Coruña, A Coruña
Magee-Womens Hospital of UPMC, Pittsburgh
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
Istituto Nazionale per la Ricerca sul Cancro di Genova, Genova
Washington Cancer Institute, Washington D.C.
Istituto Clinico Humanitas, Rozzano
Ospedale San Raffaele, Milan
IEO Istituto Europeo di Oncologia, Milan
Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), U.O Oncologia Medica, Monza
Centre Georges François Leclerc, Dijon
CARIO - Centre Armoricain de Radiothérapie, Imagerie médicale et Oncologie, Plérin
Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck
Azienda Ospealiera della Provincia di Lecco, Lecco
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII), Bergamo
CHRU Jean Minjoz, Besançon
Fondazione IRCCS Policlinico San Matteo, Pavia
Wake Forest University Baptist Medical Center, Winston-Salem
Hospital General Universitario Gregorio Maranon, Madrid
MD Anderson Cancer Centre, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Piedmont Cancer Institute, PC, Atlanta
Institut Bergonié, Bordeaux
IRCCS Centro di Riferimento Oncologico, Aviano
Florida Cancer Specialists NORTH, St. Petersburg
Florida Cancer Specialists-Broadway, Fort Myers
ICM Val d'Aurelle, Montpellier
CRLCC Eugene Marquis, Rennes
Tennessee Oncology- St Thomas Location, Nashville
Vanderbilt Breast Center at One Hundred Oaks, Nashville
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna
Norton Cancer Institute, Louisville
Universitaetsklinikum Duesseldorf AoeR, Düsseldorf
China Medical University Hospital, Taichung
Hospital Universitario Virgen Macarena, Seville
Hospital Universitario Virgen del Rocio, Seville
A.O.U. Policlinico di Modena, Modena
Azienda Ospedaliero Universitaria di Parma, Parma
The Ohio State University, Columbus
Seidman Cancer Center, Cleveland
Azienda Ospedaliera Universitaria Arcispedale Sant'Anna, Cona
ICO - Site René Gauducheau, Saint-Herblain
University of Cincinnati Medical Center, Cincinnati
Dayton Physicians, LLC, Kettering
Marienhospital Bottrop gGmbH, Bottrop
ICO - Site Paul Papin, Angers
Haematologisch-Onkologische Schwerpunktpraxis, Troisdorf
Centre de cancerologie les Dentellieres, Valenciennes
Loyola University Health System, Maywood
Centre Paul Strauss, Strasbourg
University of Nebraska Medical Center, Omaha
Centre Leon Berard, Lyon
Centre Hospitalier Lyon Sud, Pierre-Bénite
Clinique Victor Hugo - Centre Jean Bernard, Le Mans
Institut Curie - site de Paris, Paris
Hôpital Saint-Louis, Paris
Hopital Tenon, Paris
UT Southwestern Medical Center, Dallas
The University of Texas Health Science Center at Tyler, Tyler
Houston Methodist Hospital / Houston Methodist Cancer Center, Houston
MD Anderson Cancer Center, Houston
Millennium Oncology, Houston
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli
Rotkreuzklinikum Muenchen gGmbH, Munich
Klinikum rechts der Isar der TU Muenchen, Munich
Institut Sainte Catherine, Avignon
UCLA Hematology Oncology, Los Angeles
Innovative Clinical Research Institute, Whittier
Centre René Huguenin, Saint-Cloud
Sharp Memorial Hospital, San Diego
University of California San Francisco, San Francisco
Hôpital d'Instruction des Armees Begin, Saint-Mandé
Institut Gustave Roussy, Villejuif
MultiCare Health System Institute for Research and Innovation, Auburn
Azienda Ospedaliera Ospedali Riuniti Papardo-Piemonte, Messina
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Beijing Hospital, Beijing
Liaoning Cancer Hospital & Institute, Shenyang
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Fudan University Shanghai Cancer Center, Shanghai
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Sir Run Run Shaw Hospital Xiasha Branch, Zhejiang University, School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Sun Yat-sen University, Cancer Center, Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
West China Hospital, Sichuan University, Chengdu
Dana-Farber Cancer Institute, Boston
NOB - Nucleo de Oncologia da Bahia, Salvador
Hospital Nossa Senhora da Conceição, Porto Alegre
Catarina Pesquisa Clinica, Itajaí
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André
ICESP - Instituto do Cancer do Estado de São Paulo Octavio Frias de Oliveira, São Paulo
Clínica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda., São Paulo
Instituto Americas, Rio de Janeiro
A. C. Camargo Cancer Center, São Paulo
Tom Baker Cancer Centre, Calgary
Toronto Sunnybrook Hospital, Toronto
St. Mary's Hospital, Montreal
Universitaetsklinikum Erlangen, Erlangen
The Chinese, Hong Kong
The University of Hong Kong, Shatin
Center Hospital of the National Center for Global Health and Medicine, Shinjuku-Ku
Aichi Cancer Center Hospital, Aichi
NHO Shikoku Cancer Center, Ehime
NHO Kyushu Cancer Center, Fukuoka
Hiroshima City Hiroshima Citizens Hospital, Hiroshima
NHO Hokkaido Cancer Center, Hokkaido
Kanagawa Cancer Center, Kanagawa
Kumamoto University Hospital, Kumamoto
Niigata Cancer Center, Niigata
Okayama University Hospital, Okayama
NHO Osaka National Hospital, Osaka
Osaka International Cancer Institute, Osaka
Saitama Cancer Center, Saitama
Shizuoka Cancer Center, Shizuoka
National Cancer Center Hospital, Tokyo
The Cancer Institute Hospital of JFCR, Tokyo
Showa University Hospital, Tokyo
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
ICO l'Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Royal Devon and Exeter Hospital (Wonford), Exeter
Aberdeen Royal Infirmary, Aberdeen
Queen Mary University of London, London
University College London Hospitals, London
Guy's Hospital, London
Sarah Cannon Research Institute UK, London
The Christie Hospital, Manchester
Western General Hospital, Edinburgh
Nottingham University Hospitals City Campus, Nottingham
Royal Surrey County Hospital, Guildford
Lead Sponsor
Collaborators (2)
Daiichi Sankyo Co., Ltd.
INDUSTRY
AstraZeneca
INDUSTRY
Daiichi Sankyo
INDUSTRY